Table I.
Clinical characteristics of patients with hepatocellular carcinoma included in the present study (n=36).
| Clinicopathological parameters | n (%) |
|---|---|
| Sex | |
| Male | 33 (91.7) |
| Female | 3 (8.3) |
| Age, years | |
| ≥40 | 33 (91.7) |
| <40 | 3 (8.3) |
| Serum alanine aminotransferase level, U/l | |
| <50 | 21 (58.3) |
| ≥50 | 15 (41.7) |
| Hepatitis B virus surface antigen | |
| Positive | 31 (86.1) |
| Negative | 5 (13.9) |
| Serum α-fetoprotein level, ng/ml | |
| <400 | 20 (55.6) |
| ≥400 | 16 (44.4) |
| Length of tumor, cm | |
| <5 | 3 (8.3) |
| ≥5 | 33 (91.7) |
| New American Joint Committee on Cancer stage | |
| Early (I–II) | 31 (86.1) |
| Late (IIIA-IIIB) | 5 (13.9) |